INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered into...

The 2020s are seeing a silver surge as populations around the world continue to age. While Japan has the highest percentage of senior citizens in the world, other countries in Europe and North America...

New research from Harvard Medical School and Boston Children’s Hospital, in collaboration with Boston University and the University of California, Los Angeles, provides an accelerated platform for...

The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine. The European Commission, the bloc’s executive...

Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat and muscle cells. But it’s their ability to stimulate the repair of damaged...

Many of the latest developments in the global coronavirus pandemic revolve around testing—for active infection and immunity. Diagnostic and antibody tests for COVID-19 and SARS-CoV-2 are flooding the...

The European Union reopened its borders Wednesday to visitors from 15 countries—but not the virus-stricken United States, where a top health official warned the country is headed in the “wrong...

A team from Lawson Health Research Institute and Western University are the first in the world to profile the body’s immune response to COVID-19. By studying blood samples from critically ill patients...

Artificial Intelligence (AI) is increasingly being used in medicine to support human expertise. However, the potential of these applications and the risks inherent in the interaction between human and...

Alcohol-related liver disease (ALD) is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant. But now, a team led by researchers from Massachusetts...